Byeong Cheol Ahn

Title: Byeong Cheol Ahn: Innovator in Pharmaceutical Composition and Material Delivery

Introduction

Byeong Cheol Ahn is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals and material delivery systems. With a total of 3 patents to his name, Ahn's work focuses on innovative solutions for treating diseases and enhancing drug delivery methods.

Latest Patents

Ahn's latest patents include a pharmaceutical composition for treating thyroid cancer that comprises a tyrosine kinase activity inhibitor as an active ingredient. This composition aims to increase the expression of sodium iodide symporter in thyroid cancer cells, promoting iodine uptake and effectively killing cancer cells. Thus, it holds promise for the treatment of thyroid cancer. Another significant patent involves a composition for material delivery that includes exosome mimetics derived from red blood cells. This invention allows for the loading of drugs, radioactive materials, or fluorescent materials, making it useful for drug delivery, cell labeling, and diagnostic purposes.

Career Highlights

Byeong Cheol Ahn is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His work in this institution has allowed him to explore and develop innovative solutions in the pharmaceutical field.

Collaborations

Ahn has collaborated with notable colleagues, including Jae Tae Lee and Je Yeol Cho, contributing to the advancement of research and development in his areas of expertise.

Conclusion

Byeong Cheol Ahn's contributions to pharmaceutical compositions and material delivery systems highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to addressing critical medical challenges, particularly in cancer treatment and drug delivery.